Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Regeneron
Regeneron
Roche looks to compete against a blockbuster with its newly approved vision drug
Stat
Sun, 01/30/22 - 11:53 am
Roche
FDA
bispecific antibodies
Regeneron
Vabysmo
wet age-related macular degeneration
diabetic macular edema
Regeneron and Sanofi pull Libtayo app in cervical cancer, citing post-market study disagreement with FDA
Endpoints
Sun, 01/30/22 - 11:42 am
Sanofi
Regeneron
Libtayo
cervical cancer
post-marketing studies
FDA bans use of Lilly, Regeneron COVID drugs due to Omicron
Pharmaforum
Tue, 01/25/22 - 10:44 am
COVID-19
Eli Lilly
Regeneron
antibodies
Omicron COVID-19 variant
Regeneron announces FDA acceptance for sBLA review of Libtayo with chemotherapy for NSCLC
Pharmaceutical Business Review
Thu, 01/20/22 - 11:00 am
Regeneron
FDA
Libtayo
non-small cell lung cancer
Pfizer's Cibinqo snags FDA approval to challenge Sanofi and Regeneron's Dupixent in eczema
Fierce Pharma
Sun, 01/16/22 - 03:53 am
Pfizer
Sanofi
Regeneron
FDA
Cibinqo
atopic dermatitis
JPM 2022: Novartis rewrites the drug launch playbook with Leqvio, and it doesn't plan to stop there, exec says
Fierce Pharma
Thu, 01/13/22 - 11:06 am
JPMHC 2022
Novartis
Leqvio
drug launches
Regeneron
Amgen
Sanofi
Regeneron hands off ex-US rights for cholesterol disorder drug to rare disease specialist Ultragenyx
Endpoints
Fri, 01/7/22 - 10:36 am
Regeneron
evinacumab
Ultragenyx
Leo puts target on Dupixent in US as FDA clears tralokinumab
Pharmaforum
Thu, 12/30/21 - 10:45 am
Sanofi
Regeneron
Dupixent
tralokinumab
FDA
Sanofi, Regeneron plot Dupixent filing in young eczema patients, advancing drug's megablockbuster ambitions
Fierce Pharma
Mon, 12/13/21 - 11:04 am
Sanofi
Regeneron
Dupixent
eczema
pediatric
Take a deep breath: Asthma drug study failed to include Black and Puerto Rican children who could benefit most
Stat
Wed, 12/8/21 - 11:45 pm
Sanofi
Regeneron
asthma
pediatric
COVID-19
clinical trial diversity
November sees Sanofi-Regeneron dethroned after 6-month rule over top TV ad spender list
Fierce Pharma
Sun, 12/5/21 - 10:45 pm
Sanofi
Regeneron
Dupixent
DTC advertising
television ads
Regeneron warns its antibody drug may be less potent versus omicron
BioPharma Dive
Tue, 11/30/21 - 10:38 am
Regeneron
antibodies
COVID-19
Omicron COVID-19 variant
Amgen asks Supreme Court to take up its high-profile PCSK9 patent case against Sanofi and Regeneron
Fierce Pharma
Mon, 11/29/21 - 10:44 pm
Amgen
Sanofi
Regeneron
patents
Supreme Court
Repatha
Chasing Regeneron, Pfizer posts data on $250M cardiovascular bet
Fierce Biotech
Wed, 11/24/21 - 10:15 am
Pfizer
Regeneron
antisense
clinical trials
vupanorsen
dyslipidemia
Vaccibody gets a new name and loads up with nearly $1B in biobucks for new vaccine pact with Regeneron
Endpoints
Tue, 11/23/21 - 09:51 am
Vaccibody
Nykode Therapeutics
Regeneron
biobucks
cancer
infectious disease
Why Regeneron's Results for Its COVID Antibody Therapy Won't Boost Sales Much
Motley Fool
Sat, 11/20/21 - 12:01 pm
Regeneron
Roche
COVID-19
antibodies
Merck’s Anti-Cholesterol Drug Threatens Esperion, Other PCSK9 Inhibitor Makers
BioSpace
Mon, 11/15/21 - 11:55 pm
Merck
PCSK9 inhibitors
Amgen
Repatha
Esperion
Sanofi
Regeneron
Praluent
Regeneron COVID-19 antibody drug reduces infection risk 82% in clinical trial
Beckers Hospital Review
Mon, 11/8/21 - 11:03 am
Regeneron
COVID-19
antibodies
clinical trials
How Regeneron's Covid Drug Lent Itself To A Big Third-Quarter Beat
Investors Business Daily
Thu, 11/4/21 - 10:41 am
Regeneron
earnings
COVID-19
Sanofi, Regeneron gear up for new Dupixent filing after clearing second PhIII for eosinophilic esophagitis
Endpoints
Mon, 10/25/21 - 10:48 am
Sanofi
Regeneron
Dupixent
eosinophilic esophagitis
clinical trials
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »